Walgreens Boots Alliance (NASDAQ:WBA) had its price objective upped by Barclays from $77.00 to $80.00 in a research report released on Friday. Barclays currently has an equal weight rating on the pharmacy operator’s stock.
A number of other brokerages have also weighed in on WBA. BidaskClub raised shares of Walgreens Boots Alliance from a buy rating to a strong-buy rating in a research note on Friday, September 28th. ValuEngine raised shares of Walgreens Boots Alliance from a sell rating to a hold rating in a research note on Friday. Citigroup lifted their price target on shares of Walgreens Boots Alliance from $69.00 to $76.00 and gave the company a neutral rating in a research note on Friday. Robert W. Baird lifted their price target on shares of Walgreens Boots Alliance from $69.00 to $71.00 and gave the company a neutral rating in a research note on Friday. Finally, Royal Bank of Canada set a $82.00 price target on shares of Walgreens Boots Alliance and gave the company an outperform rating in a research note on Monday, October 8th. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating, seven have given a buy rating and two have given a strong buy rating to the stock. The stock has an average rating of Hold and an average target price of $77.56.
WBA traded up $2.60 during trading on Friday, reaching $73.50. The company had a trading volume of 9,645,179 shares, compared to its average volume of 6,227,956. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.47 and a current ratio of 0.93. Walgreens Boots Alliance has a 12 month low of $59.07 and a 12 month high of $80.68. The firm has a market cap of $72.35 billion, a P/E ratio of 14.41, a PEG ratio of 1.11 and a beta of 1.04.
In other news, insider Stefano Pessina bought 1,697,438 shares of the stock in a transaction that occurred on Monday, July 16th. The shares were acquired at an average cost of $63.92 per share, for a total transaction of $108,500,236.96. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction on Thursday, August 2nd. The stock was sold at an average price of $65.99, for a total transaction of $180,548.64. Following the transaction, the director now owns 10,943 shares in the company, valued at $722,128.57. The disclosure for this sale can be found here. Insiders own 14.80% of the company’s stock.
A number of institutional investors and hedge funds have recently modified their holdings of WBA. BlueMountain Capital Management LLC acquired a new position in shares of Walgreens Boots Alliance in the second quarter valued at $103,000. CSat Investment Advisory L.P. acquired a new position in shares of Walgreens Boots Alliance in the second quarter valued at $104,000. Squar Milner Financial Services LLC acquired a new position in shares of Walgreens Boots Alliance in the second quarter valued at $106,000. Kaizen Advisory LLC increased its holdings in shares of Walgreens Boots Alliance by 128.6% in the second quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock valued at $116,000 after purchasing an additional 1,083 shares during the last quarter. Finally, Camarda Financial Advisors LLC acquired a new position in shares of Walgreens Boots Alliance in the second quarter valued at $137,000. Institutional investors and hedge funds own 61.92% of the company’s stock.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Featured Article: Market Capitalization and Individual Investors
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.